Pancreatic cancer (PC) is a very lethal disease with a low survival rate, making timely and accurate diagnoses critical for successful treatment. PC classification in computed tomography (CT) scans is a vital task that aims to accurately discriminate between tumorous and non-tumorous pancreatic tissues. CT images provide detailed cross-sectional images of the pancreas, which allows oncologists and radiologists to analyse the characteristics and morphology of the tissue. Machine learning (ML) approaches, together with deep learning (DL) algorithms, are commonly explored to improve and automate the performance of PC classification in CT scans. DL algorithms, particularly convolutional neural networks (CNNs), are broadly utilized for medical i...
Objective To investigate the deep learning algorithm for automatic segmentation of pancreatic tissue...
Pancreatic cancer is a fatal malignancy with poor prognosis and limited treatment options. Early det...
Pancreatic ductal adenocarcinoma (PDAC) mortality rates are projected to rise by 2030 due to factors...
Decision-making medical systems (DMS) refer to the design of decision techniques in the healthcare s...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Early detection improves prognosis in pancreatic ductal adenocarcinoma (PDAC), but is challenging as...
Early identification of pancreatic ductal adenocarcinoma (PDAC) improves prognosis. Still, it is dif...
Artificial Intelligence and its sub-branches like Machine Learning (ML) and Deep Learning (DL) appli...
Color poster with text, images, and charts.Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive ...
The increasing incidence of pancreatic cancer will make it the second deadliest cancer in 2030. Imag...
Abstract. Automatic organ segmentation is an important yet challeng-ing problem for medical image an...
Anomalies in the pancreas regional morphology and texture may now be examined by accurately segmenti...
Objective To investigate the deep learning algorithm for automatic segmentation of pancreatic tissue...
Pancreatic cancer is a fatal malignancy with poor prognosis and limited treatment options. Early det...
Pancreatic ductal adenocarcinoma (PDAC) mortality rates are projected to rise by 2030 due to factors...
Decision-making medical systems (DMS) refer to the design of decision techniques in the healthcare s...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success ...
Early detection improves prognosis in pancreatic ductal adenocarcinoma (PDAC), but is challenging as...
Early identification of pancreatic ductal adenocarcinoma (PDAC) improves prognosis. Still, it is dif...
Artificial Intelligence and its sub-branches like Machine Learning (ML) and Deep Learning (DL) appli...
Color poster with text, images, and charts.Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive ...
The increasing incidence of pancreatic cancer will make it the second deadliest cancer in 2030. Imag...
Abstract. Automatic organ segmentation is an important yet challeng-ing problem for medical image an...
Anomalies in the pancreas regional morphology and texture may now be examined by accurately segmenti...
Objective To investigate the deep learning algorithm for automatic segmentation of pancreatic tissue...
Pancreatic cancer is a fatal malignancy with poor prognosis and limited treatment options. Early det...
Pancreatic ductal adenocarcinoma (PDAC) mortality rates are projected to rise by 2030 due to factors...